Trials / Active Not Recruiting
Active Not RecruitingNCT04950153
Intensive Combination Approach to Rollback the Epidemic in Nigerian Adolescents: UH3 Phase
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 558 (actual)
- Sponsor
- Northwestern University · Academic / Other
- Sex
- All
- Age
- 15 Years – 24 Years
- Healthy volunteers
- Accepted
Summary
Combination interventions with mHealth and Peer Navigation components will be evaluated in a randomized, stepped wedge trial among youth in Ibadan, Lagos, Sagamu, and Jos, Nigeria. Study findings will demonstrate whether or not the combination interventions for HIV testing and linkage to care and for HIV treatment outcomes, which were found to be efficacious in our prior pilot UG3 trial, will remain efficacious if scaled as proposed in this UH3 trial, across multiple sites.
Detailed description
A randomized stepped wedge (cluster) trial will be conducted to investigate two combination interventions (each with mHealth + Peer Navigation components) among youth in Ibadan, Lagos, Sagamu, and Jos, Nigeria. Study 1 (Testing and Linkage to Care) will test a combination intervention that targets HIV testing and linkage to care. Study 2 (Treatment Intervention) will test a combination intervention that targets HIV treatment outcomes (retention, adherence and viral suppression).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Peer navigation | Peer navigators will navigate youth with HIV to provide assistance and support to optimize adherence to antiretroviral treatment (ART) |
| BEHAVIORAL | SMS Text messaging | Short Message System (SMS) text messages to remind and encourage youth to adhere to their ART |
| BEHAVIORAL | Social Media Engagement | HIV testing outreach using social media platforms to promote HIV testing. |
| BEHAVIORAL | Testing Peer Navigation | Peer navigators will conduct HIV testing outreach and linkage to care to at-risk youth |
Timeline
- Start date
- 2021-04-15
- Primary completion
- 2024-08-30
- Completion
- 2024-12-31
- First posted
- 2021-07-06
- Last updated
- 2024-10-15
Locations
6 sites across 1 country: Nigeria
Source: ClinicalTrials.gov record NCT04950153. Inclusion in this directory is not an endorsement.